Approach
Team
News
Portfolio
Apply for funding
en
de
Jerini
Developing targeted peptide-based therapeutics for the treatment of rare inflammatory diseases.
IPO: 2005, Exit: 2008 Trade Sale an Shire Limited
invested since
2000
↙ Back to Portfolio
